Yucca Health is an online telemedicine platform that offers access to virtual consultations with licensed physicians, who can help customize plans to support your fitness needs. If deemed necessary, they may also offer prescriptions for compounded GLP-1 medications, which may help suppress cravings and promote metabolic health. The platform also provides arrangements for the shipping of prescriptions to your doorstep, alongside ongoing support from licensed healthcare providers.
This review explores the telehealth platform, covering aspects like its service model, the range of compounded medications, associated brand advantages, and potential limitations.
Yucca Health claims to offer personalized care services, with a focus on weight management care. It requires you to fill out an encrypted online intake form that collects insights related to your personal information and medical history. Afterwards, you can choose a program and authorize payment. Following this, a licensed clinician will review your details within 24 hours and help tailor customized plans and offer prescriptions if necessary. Once approved, your prescriptions are shipped for direct doorstep delivery.
According to the official site, the platform provides consultation access for compounded GLP-1 injectables like Tirzepatide and Semaglutide. These GLP-1 offerings may contribute to your fitness goals by supporting metabolism, suppressing appetite, and promoting fat oxidation. Such offerings are made available under the discretion of licensed providers who determine the most appropriate plan and dosing, based on your health profile and needs.
Eligibility for the brand's GLP-1 programs may depend on your medical background and body composition. As per the official site, you may qualify if your Body Mass Index is 30 or higher, or 27 or higher with some weight-related problems such as hypertension, type 2 diabetes, high cholesterol, or cardiovascular disease.
The brand claims availability of licensed healthcare providers across all 50 states within the USA, indicating a broad coverage. However, the brand does not provide insurance reimbursements, which might contribute to out-of-pocket costs.
Yucca Health provides access to consultations for compounded semaglutide as part of its GLP-1 program. According to the official website, the cost for the program starts as low as $146 per month, which includes guidance from licensed U.S.-based providers, fast medication delivery, and support from the brand's dedicated care team.
Compounded semaglutide may work by suppressing appetite and food intake by signaling the brain to control hunger and cravings. Semaglutide may also slow stomach emptying and support healthy insulin secretion, which might assist in reducing calorie intake while supporting metabolism and fitness goals.
The platform also offers access to consultations for compounded tirzepatide through its network of licensed providers. As per the official site, the cost for the brand's compounded tirzepatide program starts as low as $258 per month. Compounded tirzepatide functions as both a GLP-1 and GIP receptor agonist, meaning it acts on two essential pathways involved in blood sugar regulation. It may improve insulin response after meals and promote a sense of fullness, which may help reduce food intake and support fitness goals.
It is important to note that your prescribing provider reviews your health profile and fitness goals before recommending a starting dose (either for compounded semaglutide and tirzepatide), with adjustments made as needed to achieve the best outcomes.
Yucca Health structures its programs so you could use the funds from your Health Savings Account or Flexible Spending Account to cover eligible costs with pre-tax dollars. When your personalized program is medically indicated, you can submit payment details and documentation provided by the brand to the HSA or FSA administrator for reimbursement. The platform also offers clear records that include service descriptions, provider details, and dates of service, making the process straightforward. HSA/FSA eligibility may help you manage ongoing care expenses more efficiently and reduce out-of-pocket costs.
Yucca Health operates a nationwide telehealth network of licensed medical providers, who are authorized to practice and prescribe across all 50 states in the U.S. These providers hold an active state medical license, which may indicate that the brand's services comply with both federal and state telemedicine regulations. Such a broad licensing structure may increase the reach in every region, whether you live in large cities or rural communities. The framework may remove the need for in-person clinic visits while keeping oversight under proper state licensure standards. It may allow the brand to operate as a compliant national telehealth platform with integrated provider review and prescription coordination.
Yucca Health provides telemedicine programs that cover areas like weight management and prescription-based care. While licensed medical professionals manage these services, the brand shares limited publicly available information about the clinical studies or evidence supporting its specific protocols. The brand mainly presents general information about its GLP-1 programs without publishing measurable results, success rates, or long-term safety findings from its own clients.
Such a lack of clinical transparency may leave you with little clarity on how well the brand's programs are tested or validated in real-world scenarios. For instance, there is no detailed information about adherence outcomes for the brand's GLP-1 programs or documented monitoring of side effects over time. As a result, you may find it difficult to assess how trustworthy or evidence-based the brand's programs truly are.
Yucca Health structures its services around a subscription-based model that requires commitment to recurring monthly or quarterly payments. For example, the brand's compounded semaglutide and compounded tirzepatide programs start at a monthly subscription cost of $146 and $258, respectively. The subscription typically includes access to virtual consultations, prescription management, and continuous program monitoring, which might contribute to increased monthly expenses for the programs.
While the subscription model may support consistency and ongoing guidance, it could reduce flexibility if you prefer short-term or pay-as-you-go options. Canceling early or pausing the plan may come with conditions, such as completing a set commitment period or covering prorated charges. It can be a disadvantage if you want more control over your spending or prefer the freedom to adjust your GLP-1 programs without ongoing financial commitments.
When comparing Tryeden and Yucca Health, both function as online telehealth platforms with a focus on weight management care. However, they have some nuances in terms of their core focus and positioning, range of offerings, care model, pricing structures, and accessibility.
TryEden operates as a broad prescription wellness platform, targeting multiple wellness categories, including weight management care, strength enhancement, anti-aging, hair growth, and mood enhancement. It highlights multiple GLP-1 programs, offering access to consultations for compounded medications like Semaglutide and Tirzepatide, along with brand-name versions such as Ozempic, Mounjaro, Wegovy, and Zepbound.
Within its haircare category, the platform offers prescription access for products aimed at reducing hair loss and promoting regrowth, such as Finasteride, GHK-Cu Foam, and Minoxidil. In the strength enhancement segment, the brand provides access to prescriptions for options like Sermorelin tablets and injectables. The platform also offers access to NAD+ offerings in the form of face cream, injectables, and nasal spray, alongside Glutathione injections.
On the other hand, Yucca Health maintains a more streamlined focus, concentrating mainly on GLP-1 programs around weight management care. The platform may provide consultation access for compounded GLP-1 programs and medications through its providers, which feature compounded options like semaglutide and tirzepatide.
When it comes to added services, TryEden integrates supportive online resources that may improve your online telehealth experience. The brand features resources like online calculators for BMI, BMR, TDEE, calories, and protein intake on its official website. It also provides complementary offerings such as Eden Meals and Eden Health Clubs. Meanwhile, Yucca Health keeps its focus on the clinical aspects of the GLP-1 programs, offering a streamlined digital intake, provider review, and shipping process.
Both MEDvi and Yucca Health function within the online telehealth space, focusing on supporting fitness goals through GLP-1–based programs. These platforms may connect you with licensed healthcare providers, offer online medical evaluations, and provide delivery of compounded GLP-1 offerings to your doorstep. However, even with these shared foundations, the brands differ in aspects like their core positioning, type and range of GLP-1 offerings, pricing structure, and approaches to online care and engagement.
MEDVi positions itself as a doctor-led brand offering structured medical supervision throughout the fitness programs. For example, the brand cites partnerships with reputed and experienced doctors, such as Dr. David Mansour, Dr. Kelly Tenbrink, and Dr. Ana Lisa Carr, who have provided their professional expertise in shaping the programs. The platform also highlights its physician-reviewed approval process, 24/7 professional support, and a clear money-back guarantee as part of its program framework.
Yucca Health, meanwhile, positions itself as a science-backed telehealth platform centered on personalized care and affordability. Its focus lies in simplifying access to GLP-1 programs through customizable dosage plans and flexible payment methods such as Affirm, Klarna, and Afterpay.
When it comes to GLP-1 offerings, MEDVi provides access to consultations for both compounded and brand-name options. The platform makes available compounded semaglutide and tirzepatide in injection and tablet forms, along with brand-name injectable medications like Ozempic® through its providers. On the other hand, Yucca Health limits its focus to two programs, namely Personalized Semaglutide+ and Personalized Tirzepatide+, which are both compounded and customized based on your health profiles and needs.
Pricing structure marks another major point of difference between the platforms. For instance, the cost of MEDVi's Compounded GLP-1 Injections starts at $179 for the first month and continues at $299 for refills. Its GLP-1 Tablets are provided at a monthly subscription cost of $249, while the cost for Ozempic® injections starts at $1,999 per month, depending on availability. On the other hand, Yucca Health's subscription price for its compounded semaglutide plan starts at $146 per month, with the compounded tirzepatide plan starting at $258 per month.
Their provider networks also differ slightly in structure. As per its official website, MEDVi works in collaboration with OpenLoop Health and other affiliated physician groups, ensuring clinical oversight and prescription approval under regulated medical entities. Meanwhile, Yucca Health highlights its providers' presence in all 50 states, reflecting a more decentralized but broad telehealth network.
To evaluate Yucca Health's brand credibility, we reviewed customer feedback, platform ratings, and the brand's online presence. On Trustpilot, the brand holds a 4.5 out of 5 rating, based on over 190+ reviews shared across 2025, which typically reflects user satisfaction.
Many users noted positive outcomes with the brand's GLP-1 offerings, including improvements in fitness, energy, and body weight after a few months of use. Some described helpful interactions with the support team and found the platform's services easy to access. However, a few users have experienced delays in medication refills, while others mentioned unclear communication about subscription renewals or responses that felt scripted from the support team.
When checking for external credibility, there are no official listings for the brand on the Better Business Bureau (BBB) or TenereTeam. This could imply there is limited third-party information about the brand's reliability or complaint resolution practices. Still, the absence may not necessarily indicate a lack of credibility, it may simply reflect that the brand is still expanding its public presence.
When evaluating Yucca Health, we carefully examined what real users shared about the brand and its offerings on Reddit discussions from 2025. The overall response appeared mixed, with users expressing both good and bad experiences.
Many users described the purchase process as fast and easy, often getting approved within an hour. They also appreciated the flexible payment options through Affirm and Klarna. Some users also appreciated the clear pricing for multi-month medication plans and noted that customer service was helpful and responsive, especially when handling shipment delays or dosage questions.
However, a few Reddit users noted strange features in the compounded semaglutide, such as pink-tinted liquid or small clots near the vial tops, which made them question the product's safety. Other users expressed they had trouble confirming the legitimacy of the brand's partner pharmacies, noting that the brand works with 503a compounding pharmacies instead of 503b facilities, which usually have tighter quality control. Price was another recurring issue, with some users expressing that the $285–$385 monthly cost seemed higher than what other brands or sources offered.
Our evaluation of the brand's real user feedback indicated a balanced but cautious response. Many users appreciated the brand's convenience and speed of delivery, while others expressed doubts about product quality and transparency.
Yucca Health functions in the digital healthcare space, focusing on providing customizable GLP-1 programs to support weight management goals. Its model is built around convenience, offering home delivery of compounded medications and consistent provider follow-ups through a subscription format.
However, the brand shares limited public details about the clinical testing or measurable outcomes of its GLP-1 programs, which means you may not find clear evidence on how effective or well-validated its specific protocols are.
Moreover, the platform operates on a subscription-based model, which might contribute to higher recurring costs over time. Because of such considerations, your experience with the platform depends on some factors, including your comfort level with a fully digital care model, financial preparedness, and readiness to participate in structured programs outside of insurance coverage.
Contact us at [email protected] or follow @leafsnap on Twitter! View our Privacy Policy.
